Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors.
Rahner N, Brockschmidt FF, Steinke V, Kahl P, Becker T, Vasen HF, Wijnen JT, Tops CJ, Holinski-Feder E, Ligtenberg MJ, Spruijt L, Görgens H, Stemmler S, Kloor M, Dietmaier W; Dutch Cancer Genetics Group; Schumacher J, Nöthen MM, Propping P.
Rahner N, et al.
Fam Cancer. 2012 Mar;11(1):19-26. doi: 10.1007/s10689-011-9489-z.
Fam Cancer. 2012.
PMID: 22086303